GERMANY: ATRIX CANCER DRUG BY MEDIGENE
Article Abstract:
German Munich-based company MediGene AG has acquired from Atrix Laboratories the European marketing rights to the prostate cancer treatment Leuprogel, which is undergoing phase III clinical trials. The German company has the right to develop the drug further for other indications. It will be paying Atrix milestone and licence fees of up to US$ 20mn. The pharmaceutical will be produced by Atrix for MediGene.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
SWITZERLAND/US: ROCHE, OSI IN CANCER R&D DEAL
Article Abstract:
Roche of Switzerland and OSI Pharmaceuticals of Uniondale, US, have signed an agreement on the joint development and marketing of OSI-774, a new cancer treatment, outside the US. The US market is covered by a partnership of Genentech and OSI. The epidermal growth factor receptor is undergoing phase II clinical studies for cancers of the lung, neck, head and ovaries.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
SWITZERLAND: EUROPEAN HEADQUARTERS FOR SUGEN
Article Abstract:
San Francisco-based Sugen Inc. is setting up European headquarters in Neuhausen, northern Switzerland. The US biotechnology company with 240 staff has spent US$ 240mn in the development of three drugs for the treatment of cancer. The Swiss unit is to hire 50 staff within four years.
Publication Name: Chemische Rundschau
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0009-2983
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: SWITZERLAND/GERMANY: FOAMING AGENTS BY CLARIANT. SWITZERLAND: AXANTIS SUCCESSFUL WITH CELLULOSE. SWITZERLAND: ATISHOLZ TO GROW IN CHEMICALS
- Abstracts: TAIWAN: ZIMMER IN CHANG CHUN PLASTICS PROJECT. UZBEKISTAN: LURGI IN CHEMICALS PROJECT
- Abstracts: GERMANY: ECI, HERAEUS INVESTING IN BITTERFELD. GERMANY: KUHNE & NAGEL EXPANDS IN DUISBURG. GERMANY: HERAEUS QUARZ GLASS INVESTMENT
- Abstracts: US: KNOLL TO PAY DAMAGES. GERMANY/US: KNOLL, MYOGEN IN RESEARCH DEAL. GERMANY/US: BAYER, MYRIAD R&D INTO OBESITY
- Abstracts: Germany: Ciba completes expansion. GERMANY: NEW STRUCTURE FOR BASF PLASTICS